Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

Combating Antibiotic Resistance: Mechanisms, Multidrug-Resistant Pathogens, and Novel Therapeutic Approaches: An Updated Review

Mostafa E. ElshobaryAquaculture Research, Alfred Wegener Institute (AWI)—Helmholtz Centre for Polar and Marine Research, Am Handelshafen, 27570 Bremerhaven, GermanyNadia K. BadawyBotany and Microbiology Department, Faculty of Science, Tanta University, Tanta 31527, EgyptYara AshrafApplied and Analytical Microbiology Department, Faculty of Science, Ain Shams University, Cairo 11566, EgyptAsmaa A. ZatiounMicrobiology and Chemistry Department, Faculty of Science, Damanhour University, Damanhour 22514, EgyptHagar H. MasriyaBotany and Microbiology Department, Faculty of Science, Tanta University, Tanta 31527, EgyptMohammed AmmarMicrobiology and Biochemistry Program, Faculty of Science, Benha University-Obour Campus, Benha 13518, EgyptNourhan A. MohamedFaculty of Pharmacy, Sinai University, Ismailia 41636, EgyptSohaila MouradFaculty of Medicine, Alexandria University, Alexandria 21526, EgyptAbdelrahman M. AssyBotany and Microbiology Department, Faculty of Science, Tanta University, Tanta 31527, Egypt
2025en
ABI

Аннотация

The escalating global health crisis of antibiotic resistance, driven by the rapid emergence of multidrug-resistant (MDR) bacterial pathogens, necessitates urgent and innovative countermeasures. This review comprehensively examines the diverse mechanisms employed by bacteria to evade antibiotic action, including alterations in cell membrane permeability, efflux pump overexpression, biofilm formation, target site modifications, and the enzymatic degradation of antibiotics. Specific focus is given to membrane transport systems such as ATP-binding cassette (ABC) transporters, resistance-nodulation-division (RND) efflux pumps, major facilitator superfamily (MFS) transporters, multidrug and toxic compound extrusion (MATE) systems, small multidrug resistance (SMR) families, and proteobacterial antimicrobial compound efflux (PACE) families. Additionally, the review explores the global burden of MDR pathogens and evaluates emerging therapeutic strategies, including quorum quenching (QQ), probiotics, postbiotics, synbiotics, antimicrobial peptides (AMPs), stem cell applications, immunotherapy, antibacterial photodynamic therapy (aPDT), and bacteriophage. Furthermore, this review discusses novel antimicrobial agents, such as animal-venom-derived compounds and nanobiotics, as promising alternatives to conventional antibiotics. The interplay between clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas) in bacterial adaptive immunity is analyzed, revealing opportunities for targeted genetic interventions. By synthesizing current advancements and emerging strategies, this review underscores the necessity of interdisciplinary collaboration among biomedical scientists, researchers, and the pharmaceutical industry to drive the development of novel antibacterial agents. Ultimately, this comprehensive analysis provides a roadmap for future research, emphasizing the urgent need for sustainable and cooperative approaches to combat antibiotic resistance and safeguard global health.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 3Использованных источников: 0